Literature DB >> 29393969

Worldwide distribution of common IDUA pathogenic variants.

E Poletto1,2, G Pasqualim1,2, R Giugliani1,2,3,4,5, U Matte1,2,4, G Baldo1,2,6.   

Abstract

Mucopolysaccharidosis type I (MPS I) is a rare disorder caused by deleterious sequence variants in the α-L-iduronidase (IDUA) gene. More than 200 pathogenic variants have been described so far, but their frequencies have not yet been analyzed on a worldwide scale. To address this, we analyzed the genotypes of MPS I patients from 35 published studies papers. The most common pathogenic variant observed was p.Trp402Ter. With frequencies of up to 63%, it was the major allele in most European countries, America and Australia. The variant p.Gln70Ter was also frequent; it was found mainly in Northern and Eastern Europe. The most frequent variant in North African countries was p.Pro533Arg; in Morocco, it represented more than 90% of mutant alleles. Variants observed in East Asians were not found in Western populations, including c.1190-1G>A, p.Ala79Val, p.Leu346Arg and c.613_617dupTGCTC. Conversely, p.Trp402Ter and p.Pro533Arg were not found in patients from East Asia. In conclusion, the most common pathogenic IDUA variant in MPS I patients are p.Trp402Ter, p.Gln70Ter and p.Pro533Arg. Knowledge about the genetic background of MPS I for each population is essential when developing new genotype-targeted therapies, as well as to enable faster genetic analysis and improve patient management.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IDUA; MPS I; mucopolysaccharidosis; mutational profile; p.Gln70Ter; p.Pro533Arg; p.Trp402Ter

Mesh:

Substances:

Year:  2018        PMID: 29393969     DOI: 10.1111/cge.13224

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  14 in total

1.  A Novel Frameshift Mutation Associated with Hurler's Syndrome: A Case Report.

Authors:  Mana Kamranjam; Seyedeh Maryam Hosseini; Mohammadreza Alaei
Journal:  J Pediatr Genet       Date:  2019-04-03

Review 2.  Genomics of Alzheimer's disease implicates the innate and adaptive immune systems.

Authors:  Yihan Li; Simon M Laws; Luke A Miles; James S Wiley; Xin Huang; Colin L Masters; Ben J Gu
Journal:  Cell Mol Life Sci       Date:  2021-10-27       Impact factor: 9.207

3.  Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I.

Authors:  Dawn S Peck; Jean M Lacey; Amy L White; Gisele Pino; April L Studinski; Rachel Fisher; Ayesha Ahmad; Linda Spencer; Sarah Viall; Natalie Shallow; Amy Siemon; J Austin Hamm; Brianna K Murray; Kelly L Jones; Dimitar Gavrilov; Devin Oglesbee; Kimiyo Raymond; Dietrich Matern; Piero Rinaldo; Silvia Tortorelli
Journal:  Int J Neonatal Screen       Date:  2020-02-07

4.  "Missing mutations" in MPS I: Identification of two novel copy number variations by an IDUA-specific in house MLPA assay.

Authors:  Amir Jahic; Sven Günther; Nicole Muschol; Barbro Fossøy Stadheim; Øivind Braaten; Hanne Kjensli Hyldebrandt; Gé-Ann Kuiper; Karen Tylee; Frits A Wijburg; Christian Beetz
Journal:  Mol Genet Genomic Med       Date:  2019-07-18       Impact factor: 2.183

Review 5.  Genome Editing for Mucopolysaccharidoses.

Authors:  Edina Poletto; Guilherme Baldo; Natalia Gomez-Ospina
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923

6.  Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.

Authors:  Lorne A Clarke; Roberto Giugliani; Nathalie Guffon; Simon A Jones; Hillary A Keenan; Maria V Munoz-Rojas; Torayuki Okuyama; David Viskochil; Chester B Whitley; Frits A Wijburg; Joseph Muenzer
Journal:  Clin Genet       Date:  2019-07-02       Impact factor: 4.438

Review 7.  Mucopolysaccharidosis Type I.

Authors:  Francyne Kubaski; Fabiano de Oliveira Poswar; Kristiane Michelin-Tirelli; Ursula da Silveira Matte; Dafne D Horovitz; Anneliese Lopes Barth; Guilherme Baldo; Filippo Vairo; Roberto Giugliani
Journal:  Diagnostics (Basel)       Date:  2020-03-16

8.  Mutation analysis and clinical characterization of Iranian patients with mucopolysaccharidosis type I.

Authors:  Mohammad Taghikhani; Shohreh Khatami; Mohammad Abdi; Mohammad Said Hakhamaneshi; Mohammad Reza Alaei; Daniel Zamanfar; Rahim Vakili
Journal:  J Clin Lab Anal       Date:  2019-08-06       Impact factor: 2.352

9.  Identification of a novel compound heterozygous IDUA mutation underlies Mucopolysaccharidoses type I in a Chinese pedigree.

Authors:  Yong-An Zhou; Ping Li; Yanping Zhang; Qiuhong Xiong; Chao Li; Zhonghua Zhao; Yuxian Wang; Han Xiao
Journal:  Mol Genet Genomic Med       Date:  2019-11-23       Impact factor: 2.183

Review 10.  Pathogenic Single Nucleotide Polymorphisms on Autophagy-Related Genes.

Authors:  Isaac Tamargo-Gómez; Álvaro F Fernández; Guillermo Mariño
Journal:  Int J Mol Sci       Date:  2020-11-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.